The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multi-center phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401).
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono; Nektar
 
Michelle R. Mahoney
No Relationships to Disclose
 
Brian Andrew Van Tine
Consulting or Advisory Role - Caris Life Sciences; CytRx Corporation; EMD Serono; Johnson & Johnson; Lilly/ImClone; Novartis; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; Johnson & Johnson; Lilly; Novartis
 
James N Atkins
No Relationships to Disclose
 
Mohammed M. Milhem
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; EMD Serono; Genentech; Novartis
 
William D. Tap
Consulting or Advisory Role - Adaptimmune; Daiichi Sankyo; Eisai; EMD Serono; Immune Design; Janssen; Lilly; Novartis; Plexxikon; TRACON Pharma
 
Cristina R. Antonescu
No Relationships to Disclose
 
Laura E. Horvath
Employment - Astellas Oncology
 
Gary K. Schwartz
Honoraria - BioMotiv; Bionaut Labs; Champions Oncology; Daiichi Sankyo; DarwinHealth; Human Longevity, Inc; Karyopharm Therapeutics
Consulting or Advisory Role - BioMotiv; Bionaut Labs; Champions Oncology; Daiichi Sankyo; DarwinHealth; Human Longevity, Inc; Karyopharm Therapeutics; PureTech
Research Funding - Astex Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent pending regarding development of PNAs for targeted cancer therapy (new technology)
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Howard Streicher
No Relationships to Disclose